RETRACTED: Fahmy et al. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12, 485

Usama A Fahmy^{1

2}, Shaimaa M Badr-Eldin^{1

3}, Osama A A Ahmed^{1

2}, Hibah M Aldawsari^{1

4}, Singkome Tima⁵, Hani Z Asfour⁶, Mohammed W Al-Rabia⁶, Aya A Negm⁷, Muhammad H Sultan⁸, Osama A A Madkhali⁸, Nabil A Alhakamy^{1

2

4

9}

Affiliations

¹ Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
² Advanced Drug Delivery Research Group, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
³ Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.
⁴ Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
⁵ Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.
⁶ Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
⁷ Department of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44518, Egypt.
⁸ Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
⁹ King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

PMID: 38399352
PMCID: PMC10891988
DOI: 10.3390/pharmaceutics16020189

RETRACTED: Fahmy et al. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12, 485

Usama A Fahmy et al. Pharmaceutics. 2024.

. 2024 Jan 29;16(2):189.

doi: 10.3390/pharmaceutics16020189.

Authors

Affiliations

¹ Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
² Advanced Drug Delivery Research Group, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
³ Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.
⁴ Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
⁵ Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.
⁶ Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
⁷ Department of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44518, Egypt.
⁸ Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
⁹ King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

PMID: 38399352
PMCID: PMC10891988
DOI: 10.3390/pharmaceutics16020189

Abstract

This journal retracts the article "Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation" [...].

PubMed Disclaimer

Retraction of

Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation.
Fahmy UA, Badr-Eldin SM, Ahmed OAA, Aldawsari HM, Tima S, Asfour HZ, Al-Rabia MW, Negm AA, Sultan MH, Madkhali OAA, Alhakamy NA. Fahmy UA, et al. Pharmaceutics. 2020 May 27;12(6):485. doi: 10.3390/pharmaceutics12060485. Pharmaceutics. 2020. Retraction in: Pharmaceutics. 2024 Jan 29;16(2):189. doi: 10.3390/pharmaceutics16020189. PMID: 32471119 Free PMC article. Retracted.

References

1. Fahmy U.A., Badr-Eldin S.M., Ahmed O.A.A., Aldawsari H.M., Tima S., Asfour H.Z., Al-Rabia M.W., Negm A.A., Sultan M.H., Madkhali O.A.A., et al. RETRACTED: Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics. 2020;12:485. doi: 10.3390/pharmaceutics12060485. - DOI - PMC - PubMed
1. Fahmy U.A., Alaofi A.L., Awan Z.A., Alqarni H.M., Alhakamy N.A. Retraction Note: Optimization of Thymoquinone-Loaded Coconut Oil Nanostructured Lipid Carriers for the Management of Ethanol-Induced Ulcer. AAPS PharmSciTech. 2023;24:129. doi: 10.1208/s12249-023-02590-z. - DOI - PubMed
1. Awan Z.A., Fahmy U.A., Badr-Eldin S.M., Ibrahim T.S., Asfour H.Z., Al-Rabia M.W., Alfarsi A., Alhakamy N.A., Abdulaal W.H., Al Sadoun H., et al. The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells. Pharmaceutics. 2020;12:597. doi: 10.3390/pharmaceutics12070597. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

RETRACTED: Fahmy et al. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12, 485

Affiliations

RETRACTED: Fahmy et al. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12, 485

Authors

Affiliations

Abstract

Retraction of

References

Publication types

LinkOut - more resources

Full Text Sources